Jagoda Siemaszko
Overview
Explore the profile of Jagoda Siemaszko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
34
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dratwa-Kuzmin M, Lacina P, Wysoczanska B, Kilinska D, Siemaszko J, Sobczyk-Kruszelnicka M, et al.
J Cancer Res Clin Oncol
. 2025 Mar;
151(3):109.
PMID: 40082305
Introduction: Telomerase reverse transcriptase (TERT) is a catalytic subunit of telomerase that maintains genome stability by maintaining telomere length (TL). The massive proliferation of donor cells in the recipient's body...
2.
Siemaszko J, Lacina P, Szymczak D, Szeremet A, Majcherek M, Czyz A, et al.
Hum Immunol
. 2024 Sep;
85(6):111147.
PMID: 39332041
Despite new treatment strategies, graft-versus-host disease (GvHD) remains a formidable complication after allogeneic hematopoietic stem cell transplantation (HSCT). This study aimed to investigate the impact of polymorphisms and expression of...
3.
Bialy S, Siemaszko J, Sobczyk-Kruszelnicka M, Fidyk W, Solarska I, Nasilowska-Adamska B, et al.
Transpl Immunol
. 2024 Jul;
85:102084.
PMID: 38992477
Background: T-cell immunoglobulin and mucin-domain containing-3 (TIM-3) molecule is a key regulator of the immune response by exerting an inhibitory effect on various types of immune cells. Understanding the role...
4.
Siemaszko J, Dratwa M, Szeremet A, Majcherek M, Czyz A, Sobczyk-Kruszelnicka M, et al.
Arch Immunol Ther Exp (Warsz)
. 2024 Jun;
72(1).
PMID: 38847554
The aim of the present study was to determine the associations between the genetic variability and the expression and the risk of development of post-transplant complications after allogeneic hematopoietic stem...
5.
Siemaszko J, Lacina P, Szymczak D, Szeremet A, Majcherek M, Czyz A, et al.
Front Immunol
. 2023 Oct;
14:1227897.
PMID: 37901227
Transplantation of hematopoietic stem cells (HSCT) is a procedure commonly used in treatment of various haematological disorders which is associated with significantly improved survival rates. However, one of its drawbacks...
6.
Siemaszko J, Ussowicz M, Rybka B, Ryczan-Krawczyk R, Kalwak K, Bogunia-Kubik K
Front Genet
. 2023 Jun;
14:1186123.
PMID: 37351346
Natural Killer cells are the first subpopulation of lymphocytes that reconstitute after allogeneic haematopoietic stem cell transplantation (HSCT). Their activity is regulated by various receptor-ligand interactions, including stimulation of the...
7.
Siemaszko J, Marzec-Przyszlak A, Bogunia-Kubik K
Arch Immunol Ther Exp (Warsz)
. 2023 Mar;
71(1):9.
PMID: 36899273
The interest in NK cells and their cytotoxic activity against tumour, infected or transformed cells continuously increases as they become a new efficient and off-the-shelf agents in immunotherapies. Their actions...
8.
Siemaszko J, Marzec-Przyszlak A, Bogunia-Kubik K
Cells
. 2021 Jul;
10(6).
PMID: 34200375
Natural Killer (NK) cells are natural cytotoxic, effector cells of the innate immune system. They can recognize transformed or infected cells. NK cells are armed with a set of activating...